Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Anchord Mitral Chordal Repair System - FIH

NCT: NCT07671820 · NOT_YET_RECRUITING

NCT IDNCT07671820
StatusNOT_YET_RECRUITING
Start Date2026-07
Completion2028-12
SponsorLifecord Otd (INDUSTRY)
First posted
Last updated

Brief Summary

The goal of this clinical trial is to generate initial human clinical experience and evaluate procedural feasibility, device deployment, and early safety under controlled First-In-Human conditions for the Anchord Mitral Chordal Repair System in patients with degenerative mitral regurgitation. The main question\[s\] it aims to answer are to assess the safety of procedure, the reduction in mitral regurgitation severity and changes in hemodynamic and symptomatic status. Participants will be implanted with the Anchord device.

Frequently Asked Questions

What is Anchord Mitral Chordal Repair System - FIH?

Anchord Mitral Chordal Repair System - FIH is a clinical trial registered under NCT07671820. Current status: NOT_YET_RECRUITING.

What is the status of NCT07671820?

The current status of NCT07671820 (Anchord Mitral Chordal Repair System - FIH) is: NOT_YET_RECRUITING.

When did Anchord Mitral Chordal Repair System - FIH start?

Anchord Mitral Chordal Repair System - FIH started on 2026-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.